The impact of preoperative biological therapy on complications after abdominal surgery for inflammatory bowel disease

Gut. 2013 Mar;62(3):475-6. doi: 10.1136/gutjnl-2012-303251. Epub 2012 Jul 26.

Authors

Takayuki Yamamoto, Manabu Shiraki

PMID: 22842617
DOI: 10.1136/gutjnl-2012-303251

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Gastrointestinal Agents / therapeutic use*
Humans
Inflammatory Bowel Diseases / drug therapy*
Inflammatory Bowel Diseases / surgery*
Male

Substances

Gastrointestinal Agents